Question 1

Can I get life insurance with ulcerative colitis?

Accepted Answer

Yes. Ulcerative colitis in documented remission is broadly insurable at favorable rates. Mild UC managed with aminosalicylates and confirmed in remission by colonoscopy can qualify for standard or near-standard rates at many carriers. Active disease at the time of application typically results in postponement until remission is established.

Question 2

Does UC in remission qualify for standard life insurance rates?

Accepted Answer

Yes. Mild to moderate UC in confirmed remission — ideally supported by recent colonoscopy showing quiescent disease — can qualify for standard rates at many major carriers. Moderate UC on biologic therapy in remission typically results in Table 2 to Table 4. The key is documented remission at the time of application.

Question 3

How does biologic therapy for UC affect underwriting?

Accepted Answer

Biologics such as adalimumab or vedolizumab signal moderate to severe UC requiring more aggressive treatment. However, a good remission response on biologics is still broadly insurable at most carriers, typically at Table 2 to Table 4. Carriers evaluate the current disease state and treatment response more than the specific medication used.

Question 4

Does a colectomy for ulcerative colitis affect life insurance?

Accepted Answer

A colectomy performed for UC that has successfully resolved symptoms may actually improve the underwriting outcome compared to active medically managed disease. Post-colectomy applicants with stable health and no ongoing GI complications are evaluated on their current health status, which is often more favorable than ongoing medication-managed active disease.

Question 5

Does UC increase my life insurance rates due to colorectal cancer risk?

Accepted Answer

Long-standing ulcerative colitis carries an elevated colorectal cancer risk, which underwriters are aware of. Regular surveillance colonoscopy as recommended — with clean results and no dysplasia — is viewed positively and demonstrates active risk management. Gaps in recommended surveillance or concerning pathology findings such as dysplasia can affect the underwriting outcome.

UC Profile	Typical Rating	Best Achievable	Notes
Confirmed remission, mild disease, mesalamine only	Standard to Table 2	Standard at many carriers	Mild UC in remission is widely insurable at favorable rates
Moderate disease in remission, biologic therapy	Table 2–4	Table 2	Biologic adds rating but remains insurable in remission
Severe disease history, frequent hospitalizations	Table 4–8	Table 4 in documented remission	History of severity matters even if currently in remission
Active disease at time of application	Postponement	Postponement until remission	Apply when in confirmed remission for best outcome

Life Insurance with Ulcerative Colitis | IBD Life Insurance | High Risk

What Underwriters Evaluate for Ulcerative Colitis

UC Profile: General Underwriting Outlook

Have Ulcerative Colitis? Let’s Find Your Best Rate.

Browse All High-Risk Conditions

Ready to Protect What Matters Most?